Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study
One monthly payment covers everything with no insurance paperwork to navigate Want 24/7 access to medical support for questions about dosing, alcohol interactions , side effects, and treatment adjustments Are open to compounded medications and understand the differences from FDA-approved products MEDVi may not be the right fit if you: Have insurance that covers GLP-1 medications and want to maximize your benefits
METHODS Demographic and biochemical characteristics Among patients with SGLT2 inhibitor-associated DKA (eight males, 13 females), median age was 46.0 years (IQR, 41.0 to 61.0) and duration of diabetes was 5.0 years (IQR, 3.0 to 9.0) (Table 1)
Network analysis Analysis of inferred protein:protein interaction (PPI) networks was performed using Ingenuity Pathways Analysis software to increase confidence in the observations of differentially expressed genes by their correlation with biological pathways
